|
| | Ergoline-8-carboxylic acid, 2-bromo-9,10-didehydro-6-methyl-, (8β)- Basic information |
| Product Name: | Ergoline-8-carboxylic acid, 2-bromo-9,10-didehydro-6-methyl-, (8β)- | | Synonyms: | Ergoline-8-carboxylic acid, 2-bromo-9,10-didehydro-6-methyl-, (8β)-;Bromocriptine EP Impurity D;Bromocriptine Impurity 4（Bromocriptine Mesylate EP Impurity D);(6aR,9R)-5-Bromo-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxylic Acid;Ergoline-8-carboxylic acid, 2-bromo-9,10-didehydro-6-methyl-, (8β)- | | CAS: | 478-83-1 | | MF: | C16H15BrN2O2 | | MW: | 347.21 | | EINECS: | | | Product Categories: | | | Mol File: | 478-83-1.mol |  |
| | Ergoline-8-carboxylic acid, 2-bromo-9,10-didehydro-6-methyl-, (8β)- Chemical Properties |
| Boiling point | 579.0±50.0 °C(Predicted) | | density | 1.69±0.1 g/cm3(Predicted) | | pKa | 2.98±0.20(Predicted) |
| | Ergoline-8-carboxylic acid, 2-bromo-9,10-didehydro-6-methyl-, (8β)- Usage And Synthesis |
| Uses | 2-Bromolysergic Acid and other Lysergic Acid derivatives are ergopeptides that interact with liver cytochromes P 450. They have also been known to irreversibly inhibit serotonin containing neurons of the raphe nuclei. |
| | Ergoline-8-carboxylic acid, 2-bromo-9,10-didehydro-6-methyl-, (8β)- Preparation Products And Raw materials |
|
